Common inhaled asthma medications – dose comparison and tips for use by Woelfel, Joseph A.
University of the Pacific
Scholarly Commons
School of Pharmacy and Health Sciences Faculty
Articles
Thomas J. Long School of Pharmacy and Health
Sciences
3-1-2005
Common inhaled asthma medications – dose
comparison and tips for use
Joseph A. Woelfel
University of the Pacific, jwoelfel@pacific.edu
Follow this and additional works at: https://scholarlycommons.pacific.edu/phs-facarticles
Part of the Pharmacy and Pharmaceutical Sciences Commons
This Article is brought to you for free and open access by the Thomas J. Long School of Pharmacy and Health Sciences at Scholarly Commons. It has
been accepted for inclusion in School of Pharmacy and Health Sciences Faculty Articles by an authorized administrator of Scholarly Commons. For
more information, please contact mgibney@pacific.edu.
Recommended Citation
Woelfel, J. A. (2005). Common inhaled asthma medications – dose comparison and tips for use. Pharmacist’s Letter & Prescriber’s
Letter, 21(3), 1–7.
https://scholarlycommons.pacific.edu/phs-facarticles/50
® 
Detail-Document #210303 
−This Detail-Document accompanies the related article published in− 
PHARMACIST’S LETTER / PRESCRIBER’S LETTER 
March 2005 ~ Volume 21 ~ Number 210303 
®
 
 
More. . . 
Copyright © 2005 by Therapeutic Research Center 
Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone:  209-472-2240 ~ Fax:  209-472-2249 
www.pharmacistsletter.com ~ www.prescribersletter.com  
 
 
Common Inhaled Asthma Medications – Dose Comparison and Tips for Use 
 
Adapted from the National Asthma Education and Prevention Program, U.S. Department of Health and Human Services, National Institutes of 
Health, Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma: Update on Selected Topics 2002.  To see the full guidelines 
go to: http://www.nhlbi.nih.gov/guidelines/asthma/asthmafullrpt.pdf. 
 
 
Medication Class Drug, Dosage Form,* AWP** Adult Dose Pediatric Dose (< 12 years) 
Long-acting Inhaled 
Beta Agonists 
(including combinations) 
Salmeterol MDI (Serevent) 
21 mcg/puff, (discontinued) 
 
Salmeterol DPI (Serevent Diskus) 
50 mcg/blister, $112.10/60 dose 
 
Fluticasone/Salmeterol DPI (Advair 
Diskus) 
100 mcg, $94.01, 
250 mcg, $116.01,or 500 mcg/50 mcg, 
$163.95 
 
Formoterol DPI (Foradil Aerolizer) 
12 mcg/single-use capsule, $92.62/60 
doseDose 
2 puffs q 12 hours 
 
 
1 blister q 12 hours 
 
 
1 inhalation BID; dose 
depends on severity of 
asthma 
 
 
 
1 capsule q 12 hours 
 
1–2 puffs q 12 hours 
 
 
1 blister q 12 hours 
 
 
1 inhalation BID; dose 
depends on severity of asthma 
(not FDA approved for children < 12 
years; off-label use in 4 to 11 years of 
age using 100/50 mcg product) 
 
1 capsule q 12 hours (only for children 
> 5 years of age) 
Short-acting Inhaled 
Beta Agonists 
 
 
 
 
 
 
 
 
Albuterol MDI (Proventil, Ventolin) 
90 mcg/puff, 
200 puffs/canister, $41.34 
 
 
Albuterol HFA MDI (Proventil, 
Ventolin) 
90 mcg/puff, 
200 puffs/canister, $37.62 – $42.20 
 
 
2 puffs 5 minutes prior to exercise 
2 puffs TID-QID prn (may double 
usual dose for mild exacerbations) 
 
 
2 puffs 5 minutes prior to exercise 
2 puffs TID-QID prn (may double 
usual dose for mild exacerbations) 
 
 
 
1-2 puffs 5 minutes prior to exercise 
2 puffs TID-QID prn (may double 
usual dose for mild exacerbations) 
 
 
1-2 puffs 5 minutes prior to exercise 
2 puffs TID-QID prn (may double 
usual dose for mild exacerbations) 
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Medication Class Drug, Dosage Form,* AWP** Adult Dose Pediatric Dose (< 12 years) 
Short-acting Inhaled 
Beta Agonists 
(continued) 
Albuterol Nebulizer Solution 
(Proventil, Ventolin, AccuNeb) 
5 mg/mL (0.5%), 2.5 mg/3 mL, 
1.25 mg/3 mL, 0.63 mg/3 mL, range: 
$1.80 to $2.45/unit 
 
Levalbuterol Nebulizer Solution 
(R-albuterol) (Xopenex) 
0.31 mg/3 mL, $2.90/unit 
0.63 mg/3 mL, $2.90/unit 
1.25 mg/3 mL, $2.90/unit 
 
Pirbuterol MDI (Maxair Autohaler) 
200 mcg/puff, 
400 puffs/canister, $98.39 
 
1.25–5 mg in 3 mL of 
saline q 4–8 hours (may double dose 
for severe exacerbations) 
 
 
 
0.63 mg–2.5 mg q 4–8 hours 
 
 
 
 
 
2 puffs 5 minutes prior to exercise 
2 puffs TID-QID prn (may double 
usual dose for mild exacerbations) 
 
0.05 mg/kg (min 1.25 mg, 
max 2.5 mg) in 3 mL of 
saline q 4–6 hours  (may double dose 
for severe exacerbations) 
 
 
0.025 mg/kg (min. 0.63 mg, max. 1.25 
mg) q 4–8 hours 
 
 
 
 
1-2 puffs 5 minutes prior to exercise 
2 puffs TID-QID prn (may double 
usual dose for mild exacerbations) 
 
Anticholinergics 
(including combinations) 
Ipratropium MDI (Atrovent) 
18 mcg/puff 
200 puffs/canister, $76.80 
 
Ipratropium Nebulizer Solution 
(Atrovent) 
0.25 mg/mL (0.025%), $2.06/mL 
 
Ipratropium with Albuterol MDI 
(Combivent) 
18 mcg/puff of ipratropium bromide 
and 90 mcg/puff of albuterol 
200 puffs/canister, $85.00 
 
Ipratropium with Albuterol 
Nebulizer Solution (DuoNeb) 
0.5 mg/3 mL ipratropium 
bromide and 2.5 mg/3 mL 
albuterol, $2.36/3mL 
 
Tiotropium DPI (Spiriva) 
18 mcg/capsule, $122.98 
2–3 puffs q 6 hours 
 
 
 
0.25 mg q 6 hours 
 
 
 
2–3 puffs q 6 hours 
 
 
 
 
 
3 mL q 4–6 hours 
 
 
 
 
 
1 capsule q 24 hours 
1–2 puffs q 6 hours 
 
 
 
0.125–0.25 mg q 6 hours 
 
 
 
1–2 puffs q 8 hours 
 
 
 
 
 
1.5–3 mL q 8 hours 
 
 
 
 
 
Safety and efficacy not established in 
children 
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Medication Class Drug, Dosage Form,* AWP** Adult Dose Pediatric Dose (< 12 years) 
Mast Cell Stabilizers Cromolyn MDI (Intal) 
1 mg/puff, $103.82 
 
Cromolyn Nebulizer Solution (Intal) 
20 mg/ampule, $1.37/ ampule 
 
Nedocromil MDI (Tilade) 
1.75 mg/puff, $81.01 
2–4 puffs tid-qid 
 
 
1 ampule tid-qid 
 
 
2–4 puffs bid-qid 
 
1–2 puffs tid-qid 
 
 
1 ampule tid-qid 
 
 
1–2 puffs bid-qid 
 
Corticosteroids  
 
Beclomethasone HFA (QVAR) 
40 mcg/puff, $61.45 
Budesonide DPI (Pulmicort 
Turbuhaler) 
200 mcg/inhalation, $168.02 
Budesonide Inhalation Suspension 
for Nebulization (pediatric dose) 
(Pulmicort) 
0.25, 0.5 mg/2 mL ampule, range: 
$5.06 to $5.47/ ampule 
Flunisolide MDI (AeroBid) 
250 mcg/puff, $83.59 
Fluticasone HFA (Flovent) 
44, 110, or 220 mcg/puff, range: 
$76.73 to $159.58 
Fluticasone DPI (Flovent Rotadisk) 
50, 100, or 250 mcg/inhalation, range 
$76.73 to $159.58 
Mometasone Inhalation Powder 
(Asmanex Twisthaler)*** 
220 mcg/inhalation, $155.75 
Triamcinolone Acetonide (Azmacort) 
100 mcg/puff, $105.50 
Ranges Expressed as Low to 
Medium Daily Doses 
80–480 mcg 
 
200–1,200 mcg 
 
 
 
 
 
 
 
500–2,000 mcg 
 
88–660 mcg 
 
 
100–600 mcg 
 
 
220-440 mcg based on prior asthma 
therapy 
 
400–2,000 mcg 
Ranges Expressed as Low to 
Medium Daily Doses 
80–320 mcg 
 
200–800 mcg 
 
 
0.5-1.0 mg 
 
 
 
 
500–1,250 mcg 
 
88–440 mcg 
 
 
100–400 mcg 
 
 
(not FDA approved for children < 12 
years) 
 
400–1,200 mcg 
*  Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI), Chlorofluorocarbon (CFC), Hydrofluoroalkane (HFA) 
**  Average Wholesale Price (AWP), Cardinal Health Inc., http://www.cardinal.com.  (Accessed August 11, 2005). 
***  Approved by the FDA  in 3/05 – not included in National Asthma Guidelines 
 
Users of this document are cautioned to use their own professional judgment and consult any other necessary or appropriate sources prior to making clinical judgments based on 
the content of this document.  Our editors have researched the information with input from experts, government agencies, and national organizations.  Information and Internet 
links in this article were current as of the date of publication. 
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Tips for Correct Use of Metered Dose Inhalers (MDIs) 
 
Advantages 
• Easy-to-use and can be taken with you. 
• Sends your medicine directly into the 
large and small breathing tubes 
(bronchial tubes) of your lungs. 
• Once inhaled it quickly helps you to 
breathe better. 
• Because your medicine is delivered 
directly to your lungs it is more effective 
and causes fewer medicine-related side 
effects.  This is different from a pill or a 
shot which sends medicine to your entire 
body. 
To get the best results from your inhaler, have your healthcare professional teach you how to 
correctly use it.  Also, follow the simple tips on this sheet; they’ll serve as a reminder. 
 
Types of Inhalers 
Wet Metered Dose Inhalers Dry Powder Metered Dose Inhalers 
• Description: small canister attached to a 
mouthpiece, often “L” shaped, medicine 
and a pressurized propellant inside.  
• Propellent forces medicine into lungs as 
you breathe in. 
• Requires priming by using 2 to 3 sprays 
before first use or if not used for several 
days. 
• Shake well before each use. 
• Can be used with a spacer (a tube that 
attaches to the mouthpiece to help make the 
medicine go deeper into the lungs and 
increased effectiveness. 
• Clean the mouthpiece with water and dry. 
• Description: a single “pill” or “tube” 
shaped device (Diskus, Rotadisk, 
Turbuhaler), dry medicine is inside. 
• Your breathing in forces medicine into 
your lungs.  It does not have a propellent 
inside. 
• Does not require priming after activating 
and loading the first dose. 
• Does not require shaking. 
• No spacer is needed or should be used. 
• Clean the mouthpiece when needed with 
water and dry immediately.  Do not get the 
unit wet or place in water. 
• Capsules for inhalation (such as those used 
in the Foradil Aerolizer or Spiriva 
HandiHaler) must not be swallowed. 
 
Steps for Use 
The exact steps will be taught to you by your healthcare professional and will depend on the 
type of inhaler you have.  The steps below are common to all inhalers: 
1. Take off the cap and shake the inhaler.  If you’re using a dry inhaler, just open it.   
2. Breathe out all the way. 
3. Hold the inhaler the way you were shown.  If you are using a dry powder inhaler, 
activate it so that the powder is ready to be inhaled. 
4. As you start breathing in slowly through your mouth, press down on the inhaler.   
If you have a spacer attached to the inhaler, press down on the inhaler, wait a few 
seconds, then breathe in.   
If you use a dry powder inhaler, put the mouthpiece to your lips and breathe in 
quickly. 
5. Hold your breath as you count to 10 slowly, if you can. 
 
-Continue to the next page- 
 ®
 
Prepared for the subscribers of  
Pharmacist’s Letter / Prescriber’s Letter to give to their patients. 
P.O. Box 8190, Stockton, CA 95208  
Phone:  209-472-2240 ~ Fax:  209-472-2249 
www.pharmacistsletter.com ~ www.prescribersletter.com 
®
 
 
6. Breathe out slowly. 
7. If your prescription calls for another puff, wait about a minute, shake if you’re using a 
wet inhaler, and repeat. 
 
 
What to Do If You Have More than One Inhaler Prescription 
• One inhaler medicine (a bronchodilator) relaxes and opens the breathing tubes. 
• Another medicine (an anti-inflammatory) decreases swelling and irritation. 
• Always use the inhaler that opens the breathing tubes first (bronchodilator). 
• If your prescription calls for more than one puff, wait about a minute, and shake 
between puffs if you’re using a wet inhaler.   
• If your doctor has prescribed another inhaler, wait for 5 minutes before using it. 
• Your anti-inflammatory inhaler should be last. 
• If you have used an anti-inflammatory inhaler, always rinse your mouth with water 
and spit it out.  Doing this will prevent yeast infections in your mouth. 
 
Don’t Run Out of Your Inhalers 
Your best breathing depends on using your inhalers as your doctor prescribed.  Make sure that 
you always have enough medicine in your inhalers or you have a fresh refill on hand.   
• For inhalers that you use daily: 
o Your pharmacist can tell you how many days’ supply is in each inhaler.  When 
you start using a new inhaler write down the date it will be used up.  Don’t use it 
after that date, since the correct dose may not be delivered. To know how many 
puffs you have left in your inhaler, count the puffs you used.  
• For inhalers that you use when they’re needed for symptoms: 
o Your pharmacist can tell you how many puffs are in each inhaler.  Keep track of 
how many puffs you’ve used. 
• Some of the newer inhalers have counters on them so you’ll always know. 
• Don’t put the canister from you inhaler in water (the “float” test) to see if it’s empty, that 
doesn’t work. 
 
Storage 
Always store your inhalers at room temperature or on your person if you are going out. 
Don’t leave them in a car. 
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Proper Use of Inhaler Devices 
Lead author: Joseph A. Woelfel, Ph.D., FASCP, R.Ph., Assistant Editor 
 
Background 
Do patients say that their asthma inhaler 
medicine is not working?  If they say this, they 
may not be using it correctly.   
Misuse is common.  Patients may be using 
their inhaler longer than they should.  This often 
results from relying on inaccurate methods to 
determine how full their pressurized MDI is.1  
Failure to shake their MDI before each use is also 
commonplace.  In a small survey of asthma 
patients only 50% shook their pressurized inhaler 
before use.1  Sometimes they don’t re-shake 
between puffs.2  This can reduce the total 
medication dose delivered by 25.5% and 
“respirable” dose by 35.7%.3  Storing a 
pressurized MDI with stem-down was shown to 
reduce the total dose delivered on the first 
actuation by 25%.3 
Inappropriate storage of MDIs can cause 
considerable problems.  Many patients rely on 
mail order pharmacies for their convenience and 
because of prescription plan requirements.  With 
mail order delivery, medications are exposed to 
environmental factors in transit such as extreme 
heat or cold that can affect potency.4  Storage 
outside of controlled-room temperature, such as in 
cars, can cause problems. 
 
Commentary 
Patient education on correct use, sequencing, 
storage, and dose counting is essential.  Repeated 
reminders help to improve compliance and inhaler 
efficacy.   
If patients are using wet or pressurized MDIs, 
remind them to count the number of puffs that 
they use.  Write down the number of doses that 
they have in their “as needed” wet inhaler when 
you give it to them.  Teach them to keep a count 
and subtract the number of doses they use from 
the number you give them.  For their daily wet 
inhalers, calculate the number of days’ supply 
they have and give them that number.  Before they 
use the new inhaler, ask them to look at their 
calendar and determine the day the inhaler’s 
supply will end based on your calculated number.  
Counsel them to write this day on the actual 
inhaler as a reminder.  Newer dry or powder-
containing inhalers usually have dose counters.  
You might suggest a dry inhaler for patients with 
compliance problems, when a similar product is 
available in this form. 
Instruct patients not to place their inhaler in 
water to determine if it’s still full.5  This practice 
is potentially dangerous.2  The National Asthma 
Education and Prevention Program recommends 
counting doses.6 
Wet or pressurized inhalers also need priming 
before they are initially used or if not used for 
several days.  Remind patients about priming.  
These inhalers must be shaken before each use for 
accurate medication delivery.  Instruct patients to 
not only shake before use but also between puffs.  
For some patients the hand-breath coordination of 
these devices may be difficult.   
Dry inhalers have the advantage of not 
requiring shaking and they may be easier to use 
because they are breath-activated.  Rapid 
inspiration is needed for optimal efficacy.  This 
can be difficult for those in acute distress or for 
young children.  Dry inhalers do need to be loaded 
before their first use.  Many of the new dry 
inhalers have automatic dosage counters to 
prevent use of empty containers.  Yet, some of 
these generate an audible clicking sound when 
loading medication.  This same sound occurs if 
the device contains medication or is empty.  This 
has resulted in medication errors and adverse 
patient outcomes.7 
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Nebulizers offer effective delivery of 
respiratory medications used alone and in 
combination.  They are especially useful for 
young children and for elderly or debilitated 
patients who are unable to self-administer 
medications.   
It is always helpful to review inhaler 
sequencing with patients.  Sometimes they can 
become confused.  Remind them that their 
bronchodilator always comes first.   
Tell them to store their inhalers at room 
temperature or on their person if they are out.   
Call patients to remind them about refills and 
ask them to call you well before they run out of 
their medication.  
Your counseling actions may be reimbursable.  
Physicians and pharmacists may be paid for this 
service by appropriate coding on their billing 
forms. Billings to private insurers may require use 
of the Medicare and Medicaid 1500 claim form.  
Both the International Classification of Disease, 
Ninth Edition-Clinical Modification (ICD-9) code 
and Centers for Medicare and Medicaid Services 
Common Procedure Coding System which 
includes the Current Procedural Terminology, 
Fourth Edition (CPT-4) code must be used.  ICD-
9 codes for COPD use the 491.2 series and the 
493.9 series for asthma.  The CPT-4 code for 
demonstration and/or evaluation of correct patient 
inhalation device use is 94664.  Health 
maintenance organizations or large insurance 
companies with preventive care benefits may have 
their own billing systems and requirements.  
There can also be billing variances by state.8 
 
 
Users of this document are cautioned to use their own 
professional judgment and consult any other necessary 
or appropriate sources prior to making clinical 
judgments based on the content of this document.  Our 
editors have researched the information with input 
from experts, government agencies, and national 
organizations.  Information and Internet links in this 
article were current as of the date of publication. 
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